DF Deutsche Forfait AG / Key word(s): Capital Reorganisation 26.11.2014 12:23 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Ad-hoc announcement pursuant to § 15 WpHG DF Deutsche Forfait AG announces details of the financial restructuring concept - Offer to bondholders to exchange their bonds for shares in the context of a non-cash capital increase (debt-to-equity swap and capital increase I) - Proposal to reduce the nominal interest rate of the corporate bond 2013/2020 to 2% p.a. in return for a consideration yet to be specified - Cash capital increase of up to 6.8 million shares in March/April 2015 (capital increase II) - The lending banks have agreed to renew their credit lines and to assist in the restructuring by lowering interest rates on the condition that the other restructuring measures are implemented - Concept subject to bondholders' approval and the Annual General Meeting Cologne, 26 November 2014 - In connection with the restructuring report "IDW S6 Sanierungsgutachten" finalised this morning, DF Deutsche Forfait AG (Prime Standard ISIN: DE0005488795) announces the details of the company's financial restructuring concept. The restructuring has become necessary due to the fact that the company's operational capabilities were massively restricted between February and October 2014 due to the listing on the sanctions list of the US Office of Foreign Assets Control (OFAC). Accordingly, the parent company, DF Deutsche Forfait AG, posted a loss of approx. EUR 9.0 million for the first nine months of 2014 on the basis of preliminary figures (previous year: profit of EUR 1.3 million). This has greatly reduced the company's equity capital. As the company was removed from the sanctions list on 16 October 2014 it can now implement its established business model without any restriction whatsoever. To do this, however, the equity base needs to be strengthened to improve the company's risk-bearing capacity. At the same time, the company's financial expenses have to be reduced in order to break even again as soon as possible given the lower profitability during the relaunch phase. The company already has letters of intent from shareholders, bondholders, potential new investors and lending banks to share the restructuring measures listed below.The proposed restructuring concept essentially consists of four components: 1. Debt-to-equity swap through capital increase I In a first step, the Board of Management will make an offer to all holders of the corporate bond 2013/2020 to exchange their EUR 1,000 bonds against cash or against shares of the company in the context of a capital increase from authorised capital by up to EUR 3,400,000 through the issue of up to 3,400,000 new shares (par value: EUR 1.00) ("capital increase I"). The conversion ratio of the EUR 1,000 bonds against shares, based on an appraisal by Ebner Stolz Wirtschaftsprüfer, is expected to be announced before the end of December together with the publication of the offer following the bondholders meeting voting on this offer. Bondholders will then be given the opportunity to submit their bonds for exchange via their custodian bank. 2. Interest rate reduction and consideration yet to be specified The Board of Management additionally proposes to its bondholders to decide on the reduction of the nominal interest rate of the corporate bond 2013/2020 from 7.785% p.a. to 2.0% p.a. retroactively from May 2014 up to their maturity on 27 May 2020. In return, the Board of Management offers bondholders the possibility to exchange their conditional interest waiver against a consideration yet to be specified as an alternative to the debt-to-equity-swap (see 1. above); bondholder who hold a larger number of bonds, demanding in return the purchase of shares. The details of this exchange offer are still being elaborated and will be announced shortly. The bondholders meeting voting on this offer is to be held before the end of December 2014/ January 2015. 3. Capital increase II The Board of Management will propose to the ordinary Annual General Meeting to pass a resolution on a cash capital increase by up to EUR 6,800,000 through the issue of 6,800,000 new shares (par value: EUR 1.00) with pre-emption rights for shareholders ("capital increase II"). The Annual General Meeting is currently scheduled for 15 January 2015. Capital increase II would then be implemented in March/April 2015. 4. Interest rate cut by lending banks Moreover, the lending banks of DF Deutsche Forfait AG have expressed their general readiness to renew the credit lines in the amount granted prior to the OFAC listing until 31 December 2016 on the condition that the other restructuring measures are implemented. This also includes banks' readiness to temporarily reduce interest rates to 1% p.a. in order to assist in restructuring the company and help it recover quickly. The present restructuring concept forms the basis of the restructuring report ("IDW S6 Sanierungsgutachten") prepared by Andersch AG Wirtschaftsprüfungsgesellschaft on behalf of the company. The report confirms the company's going concern prospects on the condition that measures aimed at strengthening the company's debt and equity base are taken. Besides the measures outlined above, the report also contains the requirement to raise approx. EUR 15 million in fresh debt capital by the end of 2015. Further information regarding the timing and the exact details of the restructuring will be communicated continuously as things progress. To facilitate the communication lines, all investors of the company are asked to register in the mailing list at http://www.dfag.de/investoren-verteiler. DF Deutsche Forfait AG Christoph Charpentier Kattenbug 18 - 24 50667 Cologne T +49 221 97376-37 F +49 221 97376-60 E investor.relations@dfag.de http://www.dfag.de 26.11.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: DF Deutsche Forfait AG Kattenbug 18-24 50667 Köln Germany Phone: +49 (0)221 - 973 76 0 Fax: +49 (0)221 - 973 76 76 E-mail: dfag@dfag.de Internet: www.dfag.de ISIN: DE0005488795, DE000A1R1CC4, WKN: 548879, A1R1CC Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: DF Deutsche Forfait AG announces details of the
Top 10 Most Recent News Articles
Implantica's U.S. Launch Arrives With Cash Still to Burn
RefluxStop has finally stepped onto American soil, and that changes the conversation around Implantica in a very real way. FDA Premarket Approval arrived on August 20, then the first U.S. procedures were completed in early November at the University of Southern California. For a small medtech outfit, clearing that regulatory gate and getting actual patients treated are...
Continue Reading
Nellie's 50% Booking Jump Reveals a Quieter Luxury
Silicon Valley’s rich are apparently tired of performing wealth for strangers, and frankly, that tracks. Nellie’s 2027 forecast says its mostly tech-money clientele is moving past the old trophy case of private jets, famous resort towns, and suites priced like small houses. The prize now is privacy, a clean schedule, and somebody competent fixing the ugly little...
Continue Reading
Hyundai’s Third SUV Crown Matters Beyond the Trophy
A Three-Year Streak Is Not Just Decorative Three straight SUV-brand wins can make even a cynical car watcher pause. Hyundai has been named U.S. News & World Report’s 2027 Best SUV Brand after editors assessed vehicles from 39 brands, and that is a useful bit of outside validation in a segment where nearly everybody is throwing sheet metal, screens, and marketing dollars...
Continue Reading
NextPatient’s KLAS Marks Signal Specialty Workflow Fit
A 93.3 score in healthcare software deserves a second look. Not a victory lap, not a drumroll—just a serious look at whether the product is solving an annoying, expensive operational problem for specialty practices. NextPatient’s recognition in the 2026 KLAS Emerging Solutions Top 20 Report lands in that category. The company placed in the top five for improving...
Continue Reading
illumine Targets Childcare Chain Control and Risk Gaps
Expansion Gets Messy Before It Gets Impressive Childcare operators do not usually stumble because they forgot how to care for children; they stumble because the back office fractures as the network grows. One center handles fees one way, another lets enrollment leads work a different funnel, and headquarters discovers too late that its reports are arguing with each other....
Continue Reading
Rehab Equipment Growth Meets a Brutal Access Gap
Rehabilitation demand is piling up faster than the equipment can reach people. That is the uncomfortable fact sitting beneath Wissen Research's forecast for a global rehabilitation equipment market rising from $19.1 billion in 2026 to $25.8 billion by 2031, a 6.2% annual growth rate. It is a respectable expansion story, not some rocket-ship fairy tale. More important, it...
Continue Reading
Sinopec's Green Fuel Push Meets a Hard Reality Check
A refinery giant talking about green jet fuel at a climate summit is exactly the sort of thing that makes old energy hands squint first—and then check the asset list. Sinopec did bring more than lofty language to its Nov. 16 COP31 side event in Antalya: it brought long-range energy forecasts, named fuel-production routes, hydrogen infrastructure and operating projects....
Continue Reading
Yatsen’s November 25 Report Is the Real Beauty Test
Beauty shelves can hide a lot of sins, but earnings day tends to drag them into fluorescent light. Yatsen will release unaudited third-quarter 2026 financial results before the U.S. market opens on Wednesday, November 25, then management will take questions at 7:30 a.m. Eastern Time. For anyone following NYSE:YSG, this is not a results story yet. It is a calendar marker,...
Continue Reading
Dutch Solar Homes Face a 2027 Net Metering Reset Ahead
A policy switch buried in a Dutch calendar is about to rearrange millions of kitchen-table energy calculations. On 1 January 2027, the Netherlands ends net metering, or salderingsregeling, and households with solar panels will no longer offset exported power against electricity bought from the grid. That is not some abstract regulatory footnote. It changes the value of...
Continue Reading
Misunderstood Brands Bets Small Cans Can Scale Growth
A tiny cocktail can is a brutal little test of whether a spirits brand has legs. Misunderstood Brands is putting four 100mL offerings on the shelf just as its Wegmans distribution expands across the East Coast, and that combination matters more than another glossy flavor announcement. The company is trying to turn products people discovered in bars and restaurants into...
Continue ReadingTop 5 Most Recently Viewed Articles
DallasNews Shareholders Urged to Support Merger Deal with Hearst
Overview of the DallasNews and Hearst Merger DallasNews Corporation, the parent company of The Dallas Morning News, has proposed a significant merger with Hearst, a prominent media organization. This merger offers an enticing cash value of $15.00 per share, bringing impressive benefits to shareholders. Recently, Glass Lewis, an independent proxy advisory firm, recommended...
Continue Reading
GitLab Director Karen Blasing's Recent Stock Transactions Explained
Analyzing the Recent Insider Trading at GitLab GitLab Inc. (NASDAQ:GTLB) has recently drawn the attention of investors and market analysts due to stock transactions made by its director, Karen Blasing. A recent filing with the U.S. Securities and Exchange Commission revealed that Blasing sold a considerable amount of her stock holdings, totaling more than $173,000....
Continue Reading
Avenue Living's Strategic $350 Million Debenture Offering
Avenue Living Announces $350 Million Senior Unsecured Debenture Offering Avenue Living (2014) LP has recently announced a significant financial move with a $350 million offering of Series B senior unsecured debentures. This opportunity is set to be priced at par and is due by September 25, 2028, indicating a long-term strategy for the company’s financing needs. Details...
Continue Reading
Fagron Reports Strong Financial Growth with Strategic Outlook
Fagron's Remarkable Financial Performance Fagron, a global leader in pharmaceutical compounding, recently showcased its impressive results for the period ending December 31, 2024. The company’s financial achievements highlight significant growth across various sectors and regions in the pharmaceutical industry, reinforcing its commitment to excellence and innovation....
Continue Reading
Dizal's Sunvozertinib Receives Breakthrough Therapy Designation
Dizal's Sunvozertinib Achieves Breakthrough Therapy Designation Dizal, a biopharmaceutical company dedicated to developing innovative cancer and immunological therapies, recently announced an important milestone. The Center for Drug Evaluation of China's National Medical Products Administration has granted Breakthrough Therapy Designation for sunvozertinib, aimed at...
Continue Reading